BIOSCIENCE VALUATION

Our Products

We offer all services and analytics required to evaluate life science assets.

Market Model

Bioscience Valuation’s Market Model is a user-friendly Excel®-based program that allows to assess a drug’s sales potential. Key advantages of Bioscience Valuation’s market model are:

  • user-friendliness and enhanced flexibility,
  • ability to stratify patients,
  • the model suggests estimations of potential market share based on the expected efficacy benefit of a drug,
  • predictions of market share are based on advanced mathematical algorithms that consider the likelihood of launch of competing drugs,
  • ability to be combined with a pharmacoeconomic module to estimate cost-effectiveness that enhances its utility and adaptability.
  • Bioscience Valuation can provide all required inputs to the model and complete commercial assessments for clients who want to take advantage of Bioscience Valuation’s resources.

“We greatly enjoy working with Bioscience Valuation; the company’s ‘Corporate Partnership Program’ is a great offering that provides in-depth analyses of significant economic value at fair cost.”

Dr. Ulrich Jahnel, Senior VP, Head of External Innovation, Grünenthal